PharmaEngine Inc 2022 SR
The report highlights PharmaEngine's commitment to oncology drug development and sustainability through its virtual pharmaceutical business model. In 2022, the company achieved significant milestones, including the successful Phase 3 trial for Onivyde as a first-line pancreatic cancer therapy and the advancement of PEP07 into clinical trials. PharmaEngine strengthened its governance by establishing a Sustainability Promoting Taskforce and obtaining ISO 27001 certification for information security. Environmental efforts focused on greenhouse gas inventorying and resource conservation, while social initiatives included hosting health education seminars for pancreatic cancer patients and conducting beach cleaning activities.
Company: PharmaEngine Inc
Sector: Health Care
Country: Taiwan
Year: 2022
Type: SR
Pages: 86
PharmaEngine Inc
Sustainability Report
The report highlights PharmaEngine's commitment to oncology drug development and sustainability through its virtual pharmaceutical business model. In 2022, the company achieved significant milestones, including the successful Phase 3 trial for Onivyde as a first-line pancreatic cancer therapy and the advancement of PEP07 into clinical trials. PharmaEngine strengthened its governance by establishing a Sustainability Promoting Taskforce and obtaining ISO 27001 certification for information security. Environmental efforts focused on greenhouse gas inventorying and resource conservation, while social initiatives included hosting health education seminars for pancreatic cancer patients and conducting beach cleaning activities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Sep 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Workplace Fatalities
Employees